Lisa Beth Ferstenberg

Dr. Ferstenberg is a seasoned biopharmaceutical serial entrepreneur with expertise in clinical development of products for anti-cancer, immunology and infectious disease applications, spanning new drugs, vaccines, targeted immunotherapies, stem cells and biotech innovations. Ms. Ferstenberg is the founding CEO for Collective Therapeutics, Inc., a venture backed company that licensed a selective monoclonal antibody for the treatment of autoimmunity from Duke University and three other co-licensing institutions.